North America Vitro Toxicology Testing Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 11,902.69 |
 CAGR |
% |
| Major Markets Players |
>北美体外毒理学测试市场，按产品和服务（消耗品、服务、分析、设备和软件）、毒理学终点和测试（ADME（吸收、分布、代谢和排泄）测试、细胞毒性测试、遗传毒性测试、皮肤毒性测试、眼部毒性测试、器官毒性测试、皮肤刺激、腐蚀和致敏测试、光毒性测试和其他毒性终点和测试）、技术（细胞培养技术、高通量技术、分子成像和 OMICS 技术）、方法（细胞分析、生化分析、体外模型和计算机模型）、行业（制药和生物制药公司、诊断、食品、化学品、化妆品和家用产品）、分销渠道（直接招标、零售销售等） - 行业趋势和预测到 2030 年。
北美体外毒理学测试市场分析和规模
北美体外毒理学测试市场本质上是分散的，因为它由许多北美参与者组成，例如 Thermo Fisher Scientific Inc.（美国）、Labcorp Drug Development（美国）、Merck KGaA（德国）、Charles River Laboratories（美国）和 Bio-Rad Laboratories, Inc.（美国）等。这些公司的存在为整个地区的体外毒理学测试产品提供了具有竞争力的价格。由于这些参与者在区域和国际层面的存在，供应商和制造商提供具有不同规格和特性的产品，价格范围涵盖所有预算。对体外毒理学测试产品的需求不断增长推动了市场增长。此外，快速增长的制药和医疗行业预计将推动市场增长。
Data Bridge Market Research 分析，北美体外毒理学测试市场预计到 2030 年将达到 119.0269 亿美元，预测期内复合年增长率为 14.0%。由于患者对毒性测试产品的需求不断增加，产品和服务部分占市场最大份额。本市场报告还深入介绍了定价分析、专利分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
产品和服务（消耗品、服务、测定、设备和软件）、毒理学终点和测试（ADME（吸收、分布、代谢和排泄）测试、细胞毒性测试、遗传毒性测试、皮肤毒性测试、眼部毒性测试、器官毒性测试、皮肤刺激、腐蚀和致敏测试、光毒性测试和其他毒性终点和测试）、技术（细胞培养技术、高通量技术、分子成像和 OMICS 技术）、方法（细胞测定、生化测定、离体模型和计算机模型）、行业（制药和生物制药公司、诊断、食品、化学品、化妆品和家用产品）、分销渠道（直接招标、零售销售和其他） |
|
覆盖国家 |
美国、加拿大和墨西哥 |
|
涵盖的市场参与者 |
Thermo Fisher Scientific Inc.、Labcorp Drug Development、Merck KGaA、Charles River Laboratories、Lonza、Bio-Rad Laboratories, Inc.、Catalent, Inc、SGS Société Générale de Surveillance SA、QIAGEN、Intertek Group plc.、Eurofins Scientific、Promega Corporation、Aragen Life Sciences Ltd.、Cyprotex Plc.、上海美迪西生物技术有限公司、Creative Biolabs、BioIVT、AAT Bioquest, Inc.、Gentronix、IONTOX、InSphero、MB Research Laboratories、Creative Bioarray 和 Preferred Cell Systems |
市场定义
体外毒理学测试涉及使用体外（非动物）测试方法测试化学品、药物和其他物质以评估其潜在毒性。体外毒理学测试涉及使用自然环境之外的细胞、组织或细胞成分来评估物质的安全性和潜在危害。市场涵盖各种体外测试和检测，用于评估毒性的各个方面，包括但不限于细胞毒性、遗传毒性、致癌性、器官毒性、生殖毒性和环境毒性。这些测试是在细胞培养物、组织模型或其他体外系统上进行的，以模拟生物系统对潜在毒物的反应。
北美体外毒理学测试市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
毒理学检测产品需求不断增长
制药行业的主要活动是质量管理。药品必须以无菌、具有治疗活性、可靠且性能可预测的配方出售。新的和改进的药剂正在加速开发。与此同时，正在开发更精确和更复杂的分析方法来评估它们。由于慢性病发病率的上升和 COVID-19 大流行的出现，对药品和医疗器械的需求也相应增加。随着对生物技术和制药行业产品的需求增加，对毒理学测试的需求进一步增加，
毒理学研究是药物开发的一个重要部分，用于通过确定药物对器官结构/功能的影响来描述药物的毒性特征。该研究提供了关键信息和知识，监管机构等机构可以利用这些信息和知识来预防或降低疾病或其他负面健康结果发生的可能性。食品和药物管理局已经发布了多份行业指导文件，例如药物代谢物的安全性测试、体外代谢和转运体介导的药物相互作用研究以及临床药物相互作用研究。
快速增长的制药和医疗器械行业
制药和医疗器械行业见证了许多革命性的趋势和进步，极大地改善了患者可获得的药物。我们可以看到人工智能和大数据对疾病诊断和治疗的影响。
生物制药的有效性和保护性加上其治疗以前无法治愈的疾病的潜力，有助于制药公司取得成功。持续健康增长的机会支持现有的生物制剂开发渠道。自 1995 年以来，生物技术专利申请数量每年增长 25%。目前有 1,500 多种生物分子正在接受临床试验，生物制剂的成功率迄今为止是小分子药物的两倍多，13% 的生物制药进入 I 期测试阶段并开始上市。
这些行业的繁荣和发展也相应增加了对其所开发产品的质量控制所需的毒性测试需求。因此，快速增长的制药和医疗器械行业成为市场增长的驱动力。
机会
越来越多地采用质量检查产品来防止产品召回
医疗设备、药品和生物制剂在当今的医疗保健服务中发挥着越来越重要的作用。然而，持续存在的药品质量问题和相关召回问题可能会对患者使用这些药品的健康造成危害。制药公司召回产品的主要原因之一是其药品和其他产品的毒性，这些毒性可能会对服用这些药品的患者造成严重的健康问题。有详细的报告称毒性对人类可能造成毁灭性的影响。毒素在血液中达到足够浓度时通常会引发永久性副作用，在极端情况下甚至会导致死亡。
跟踪毒性存在的过程控制必须包括复合产品的无菌生产。因此，在制药和生物医学行业，有效和高效地监测毒性的存在非常重要。所有标记为无热原或无菌的注射或植入产品在发布前都必须经过毒理学测试。这可以避免患者中毒，并使其易于遵守监管和 cGMP 指南。因此，越来越多地采用质量检查产品来防止产品召回，为市场增长提供了机会。
克制/挑战
体外毒理学测试和产品成本高昂
自动毒性测试系统配备了最新技术和先进功能。它们具有广泛的功能和特性。自动化 AST 可以高效准确地检测毒性。然而，这些设备的高成本可能会影响市场。
资金投入成本高是市场最大的制约因素。新产品的开发需要深入的研究和临床研究。毒性测试的技术创新已经实现了早期检测，但由于其技术最新且改进，因此需要大量的资金投入。
因此，进步包括自动抗菌药敏试验 (AST) 系统）微量稀释、快速自动仪器方法、MIC 试纸测试、基因型方法、纸片扩散法、电子测试和 POCT 兼容技术，所有这些先进功能都使设备成本高昂。这可能是体外毒理学测试市场的一个制约因素。
最新动态
- 2023 年 6 月，北美制药、生物技术和营养保健品市场制造合作伙伴 Lonza 宣布已收购 Synaffix BV (Synaffix)，后者是一家专注于将其临床阶段 ADC 开发技术平台商业化的生物技术公司。这将有助于该公司扩大其在北美的业务。
- 2023 年 5 月，Labcorp Drug Development 和 BML 宣布扩大在日本的临床实验室检测能力。这将有助于该公司加强其在该地区的产品组合。
- 2022 年 12 月，领先的科技公司 Merck KGaA 今天宣布与美国马萨诸塞州剑桥市的 Mersana Therapeutics, Inc. 达成研究合作和商业许可协议，利用 Mersana 专有的 Immunosynthen STING 激动剂 ADC 平台发现新型抗体-药物偶联物 (ADC)，针对最多两个靶点。
- 2022 年 10 月，赛默飞世尔科技公司宣布将扩大其位于肯塔基州高地高地的实验室业务，帮助客户为患者提供改变生活的药物。目前的设施包括中央实验室和生物标志物业务，为生物制药客户提供高质量的实验室服务，以加速药物开发。这有助于公司在世界各地扩展其临床诊断业务，并有助于提高北美市场的存在感。
- 2021 年 12 月，Aragen Life Sciences Ltd. 收购了 Intox Pvt. Ltd.，以加强其安全评估平台，这有助于该公司确立自己的地位。
北美体外毒理学测试市场范围
北美体外毒理学测试市场分为六个显著的细分市场，例如产品和服务、毒理学终点和测试、技术、方法、行业和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
产品与服务
- 耗材
- 服务
- 检测
- 设备
- 软件
根据产品和服务，市场细分为消耗品、服务、分析、设备和软件。
毒理学终点和测试
- ADME（吸收、分布、代谢和排泄）测试
- 细胞毒性测试
- 遗传毒性测试
- 皮肤毒性测试
- 眼部毒性测试
- 器官毒性测试
- 皮肤刺激、腐蚀和致敏性测试
- 光毒性测试
- 其他毒性终点和测试
根据毒理学终点和测试，市场细分为 ADME（吸收、分布、代谢和排泄）测试、细胞毒性测试、遗传毒性测试、皮肤毒性测试、眼部毒性测试、器官毒性测试、皮肤刺激、腐蚀和致敏测试、光毒性测试以及其他毒性终点和测试。
技术
- 细胞培养技术
- 高通量技术
- 分子成像
- OMICS 技术
根据技术，市场细分为细胞培养技术、高通量技术、分子成像和 OMICS 技术。
方法
- 细胞检测
- 生化检测
- 离体模型
- 计算机模型
根据方法，市场分为细胞测定、生化测定、离体模型和计算机模型。
行业
- 制药及生物制药公司
- 诊断
- 食物
- 化学品
- 化妆品和家居用品
根据行业，市场分为制药和生物制药公司、诊断、食品、化学品、化妆品和家用产品。
分销渠道
- 直接招标
- 零售销售
- 其他的
根据分销渠道，市场分为直接招标、零售销售和其他。
北美体外毒理学测试市场区域分析/见解
对北美体外毒理学测试市场进行分析，并根据国家、产品和服务、毒理学终点和测试、技术、方法、行业和分销渠道提供市场规模信息。
本市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于对体外毒理学检测产品的需求不断增长，预计美国将在北美占据主导地位。这一份额归因于 Labcorp Drug Development、Thermo Fisher Scientific Inc.、Charles River Laboratories、Merck KGaA 和 Bio-Rad Laboratories, Inc. 等主要市场参与者的存在。预计在预测期内，对毒理学检测和技术进步的需求不断增长将推动该地区的市场增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。
竞争格局和北美体外毒理学测试市场份额分析
北美体外毒理学测试市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、新市场计划、区域存在、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
北美体外毒理学测试市场的一些主要市场参与者包括赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.)、Labcorp Drug Development、默克公司 (Merck KGaA) 和 Charles River Laboratories 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS ANALYSIS
5 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, INDUSTRY INSIGHTS
6 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING DEMAND FOR TOXICOLOGY TESTING PRODUCTS
7.1.2 RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES
7.1.3 RISING INVESTMENT IN R&D BY KEY MARKET PLAYERS
7.1.4 TECHNOLOGICAL ADVANCEMENTS TO DEVELOP NEW TOXICOLOGY TESTING METHODS
7.2 RESTRAINTS
7.2.1 HIGH COSTS ASSOCIATED WITH IN-VITRO TOXICOLOGY TESTING AND PRODUCTS
7.2.2 COMPLEXITY OF BIOLOGICAL SYSTEMS
7.2.3 NEED FOR SKILLED PERSONNEL AND INFRASTRUCTURE
7.3 OPPORTUNITIES
7.3.1 GROWING ADOPTION OF QUALITY CHECK PRODUCTS TO PREVENT PRODUCT RECALLS
7.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS FOR MARKET EXPANSION
7.3.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND PRECISION TOXICOLOGY
7.4 CHALLENGES
7.4.1 ETHICAL AND PUBLIC PERCEPTION
7.4.2 REGULATORY ACCEPTANCE AND ENDORSEMENT OF IN-VITRO TESTING METHODS
8 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE
8.1 OVERVIEW
8.2 CONSUMABLES
8.3 SERVICES
8.3.1 CYTOTOXICITY
8.3.2 GENE TOXICITY
8.3.3 HEPATOTOXICITY
8.3.4 OPHTHALMIC TOXICITY
8.3.5 CARDIOTOXICITY
8.3.6 NEPHROTOXICITY
8.3.7 NEUROTOXICITY
8.3.8 OTHERS
8.4 ASSAYS
8.4.1 CELL-BASED ELISA & WESTERN BLOTS
8.4.2 ENZYME TOXICITY ASSAYS
8.4.3 RECEPTOR-BINDING ASSAYS
8.4.4 BACTERIAL TOXICITY ASSAYS
8.4.5 TISSUE CULTURE ASSAYS
8.4.6 OTHER ASSAYS
8.5 EQUIPMENTS
8.6 SOFTWARE
9 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST
9.1 OVERVIEW
9.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
9.3 CYTOTOXICITY TESTING
9.4 GENOTOXICITY TESTING
9.5 DERMAL TOXICITY TESTING
9.6 OCULAR TOXICITY TESTING
9.7 ORGAN TOXICITY TESTING
9.8 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
9.9 PHOTOTOXICITY TESTING
9.1 OTHER TOXICITY ENDPOINTS AND TESTS
10 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 CELL CULTURE TECHNOLOGIES
10.3 HIGH-THROUGHPUT TECHNOLOGIES
10.4 MOLECULAR IMAGING
10.5 OMICS TECHNOLOGY
11 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD
11.1 OVERVIEW
11.2 CELLULAR ASSAYS
11.3 BIOCHEMICAL ASSAYS
11.4 EX-VIVO MODELS
11.5 IN SILICO MODELS
12 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
12.2.1 CONSUMABLES
12.2.2 SERVICES
12.2.3 ASSAYS
12.2.4 EQUIPMENTS
12.2.5 SOFTWARE
12.3 DIAGNOSTICS
12.3.1 CONSUMABLES
12.3.2 SERVICES
12.3.3 ASSAYS
12.3.4 EQUIPMENTS
12.3.5 SOFTWARE
12.4 FOOD
12.4.1 CONSUMABLES
12.4.2 SERVICE
12.4.3 ASSAYS
12.4.4 EQUIPMENTS
12.4.5 SOFTWARE
12.5 CHEMICALS
12.5.1 CONSUMABLES
12.5.2 SERVICES
12.5.3 ASSAYS
12.5.4 EQUIPMENTS
12.5.5 SOFTWARE
12.6 COSMETICS AND HOUSEHOLD PRODUCTS
12.6.1 CONSUMABLES
12.6.2 SERVICES
12.6.3 ASSAYS
12.6.4 EQUIPMENTS
12.6.5 SOFTWARE
13 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 LABCORP DRUG DEVELOPMENT
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 CHARLES RIVER LABORATORIES.
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 LONZA
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 AAT BIOQUEST, INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 ARAGEN LIFE SCIENCES LTD.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BIOIVT
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO-RAD LABORATORIES, INC.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 CATALENT, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 CREATIVE BIOARRAY.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 CREATIVE BIOLABS.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 CYPROTEX LIMITED
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 EUROFINS SCIENTIFIC
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 GENTRONIX
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 IONTOX
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 INSPHERO.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 INTERTEK GROUP PLC
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENT
17.19 MB RESEARCH LABORATORIES
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 PREFERRED CELL SYSTEMS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PROMEGA CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 QIAGEN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 SHANGHAI MEDICILON INC.
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 27 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 28 U.S. SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 29 U.S. ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 30 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 31 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 32 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 33 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 34 U.S. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 35 U.S. DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 36 U.S. FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 37 U.S. CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 38 U.S. COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 39 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 40 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 41 CANADA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 42 CANADA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 43 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 44 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 45 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 46 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 47 CANADA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 48 CANADA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 49 CANADA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 50 CANADA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 51 CANADA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 52 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 53 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 54 MEXICO SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 55 MEXICO ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 56 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 57 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 58 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 59 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 60 MEXICO PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 61 MEXICO DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 62 MEXICO FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 63 MEXICO CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 64 MEXICO COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 65 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR TOXICOLOGY TESTING PRODUCTS AND RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL INDUSTRIES ARE EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET FROM 2023 TO 2030
FIGURE 12 THE CONSUMABLES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET
FIGURE 14 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2022
FIGURE 15 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2022
FIGURE 19 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2020-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, LIFELINE CURVE
FIGURE 22 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2022
FIGURE 23 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 26 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2022
FIGURE 27 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, LIFELINE CURVE
FIGURE 30 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2022
FIGURE 31 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, LIFELINE CURVE
FIGURE 34 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 39 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 40 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 43 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
